Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention. [electronic resource]
Producer: 20110310Description: 686-92 p. digitalISSN:- 1932-8737
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- administration & dosage
- Chi-Square Distribution
- Cost Savings
- Drug Costs
- Drug Substitution
- Eptifibatide
- Female
- Hospitals, University
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Peptides -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Proportional Hazards Models
- Registries
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Stroke -- etiology
- Sweden
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.